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Abstract 
Background and purpose 
Nitric oxide (NO) has been well documented as a potent, endogenous vasodilator. 
The effects of NO within the pulmonary and systemic vasculature have been 
investigated to some degree but the mechanisms behind its regulation are not fully 
understood. Mitochondria have been shown to regulate potassium channels that are 
important in the regulation of vascular tone. This study aims to observe the effects of 
mitochondrial inhibition of the electron transport chain at different complexes and 
within different vascular tissues to further elucidate this system. 
Experimental approach 
I examined the effects of mitochondrial transport chain inhibitors rotenone (inhibition 
at complex 3) and antimysin-A (inhibition at complex 1) on the relaxation of rat aortic 
and pulmonary vessels, induced by sodium nitroprusside (SNP). 
Key results 
Inhibition of mitochondrial electron transport chain at complex 1 surprisingly caused 
a great increase in levels of vasodilation within the pulmonary artery. Inhibition of 
mitochondrial electron transport chain at complex 1 also caused an increase of SNP 
induced vasodilation within the aorta. Inhibition of the mitochondrial electron 
transport chain at complex 3 resulted in a markedly decreased vasodilatory effect of 
SNP on the aorta. 
Conclusions and implications 
My results demonstrate the importance of mitochondrial activity in the regulation of 
NO’s vasodilator action within the pulmonary and systemic vasculature. It also 
highlights the relevance of activity at certain complexes within the mitochondrial 
electron transport chain, suggesting a strong correlation between redox state and co-
localised potassium channels. This promotes further research into the specificity of 
activity at certain complexes and the potential for further development of therapeutic 
NO donors in the treatment of cardiovascular disorders. 
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Introduction 
The effects of endothelial dysfunction through processes such as aging have been 
well documented and for many years it has been well understood that this has major 
contributions to cardiovascular disorders, which are a massive burden on society, 
being the leading cause of morbidity and mortality world-wide, with over 17 million 
deaths from cardiovascular disease recorded in 2008 (Sidney and Smith 2010). 
Many cardiovascular diseases have been linked to some level of impairment of 
endothelial vasorelaxation and one of the most important signalling molecules, 
relating to endothelial function, is nitric oxide (NO). NO has many effects on vascular 
functioning through endothelial signalling, including anticoagulation, leucocyte 
adhesion, smooth muscle proliferation, and the antioxidative capacity (Gewaltig and 
Kojda 2002), however one of the most important protective effects it has is that of 
vasodilation. NO’s vasodilatory properties are attenuated as a result of many 
cardiovascular pathologies.  
 
NO achieves its vasodilatory action through a number of mechanisms. The most 
prominent and well understood of these is the cGMP pathway. Upon the increased 
production by the endothelium, NO binds to soluble guanylate cyclase (sGC) and 
activates it (Denninger and Marletta 1999). NO has a high affinity for sGC because 
of the presence of the heme protoporphyrin IX which contains ferrous form iron 
(Pacher et al. 2007). It is the single unpaired electron which give NO its high affinity 
to protoporphyrin IX, in comparison to other molecules. As there is only one free 
electron the binding of NO is a chain terminating reaction. For this reason NO has 
10,000 fold greater affinity for deoxyhaemoglobin than O2, allowing it to take effect at 
extremely low concentrations (Pacher et al. 2007). Once bound, NO activates sGC 
which, in turn, causes the production of cGMP. This then goes on to activate protein 
kinase G (PKG) which has the ability to phosphorylate a number of molecules, 
responsible for the cell signalling pathways which cause vasodilation (White et al. 
2000). This includes phosphorylation of potassium channels in smooth muscle and 
endothelial cells. It also works by phosphorylating a serine residue on myosin light 
chains in smooth muscle cells to desensitise the contractile apparatus resulting in 
vasodilation (Mingone et al. 2003). 
 
Vascular tone is regulated through a number of mechanisms. One of the most 
important factors to come to the forefront of recent research is through the mediation 
of potassium channels. In vascular smooth muscle cells these channels exist in three 
main groups. These are the calcium activated potassium channels, the voltage 
dependent potassium channels and the ATP-sensitive potassium channels (Korthuis 
2011). The calcium activated potassium channels open as a result of raised 
intracellular calcium concentration and result in potassium flux out of the cell, 
resulting in cell becoming more hyperpolarised. They range from small to large 
conductance groupings (Gutterman et al. 2005) and result in the closing of calcium 
channels, preventing calcium influx and causing vasodilation. These channels are 
present on both the endothelium and vascular smooth muscle cells (Brayden 1996). 
The voltage gated potassium channels work to the same effect as the calcium 
activated channels, however their location is specific to vascular smooth muscle cells 
(Figueroa et al. 2007). The ATP-sensitive channels are mediated by the ADP-ATP 
ratio in the near vicinity which may link them strongly to local mitochondrial activity. 
They are found in both the endothelial and vascular smooth muscle cells (Nelson 
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and Quayle 1995). It should be noted that these channels are not only sensitive to 
ADP-ATP ratio but may also be activated by protein kinases as a downstream result 
of cGMP and cAMP activation. This highlights the importance of NO in potassium 
channels activity. Research has shown that, in conditions of hypoxia, levels of NO 
are elevated, increasing the activity of cGMP and therefore PKG, resulting in the 
phosphorylation and activation of these potassium channels, increasing cytosolic 
calcium levels in endothelial cells (Hampl et al. 1995).  
 
NO is synthesised in endothelial cells as a result of intracellular calcium level 
perturbation (Stamler et al. 1994). It is synthesised from L-arginine and requires the 
presence of several molecules, including oxygen, heme, FAD, NADPH, 
tetrahydrobiopterin and calmodulin. NO is produced alongside L-Citrulline and the 
mediation of many of the necessary cofactors is regulated by mitochondrial activity 
(Toda et al. 2009). NO within the pulmonary and systemic vasculature is produced 
by eNOS (endothelias NO synthase), which is a constitutive enzyme, always present 
in cells and with the potential for rapid modification of its activity (Dale and Haylet 
2004). In conditions of raised cytosolic calcium levels, eNOS is activated through its 
binding to caveolin-1 in the caveolae, causing it to migrate into the cell in its active 
form (Toda et al. 2009).  
  
Figure 1: Taken from (Queliconi 2010). Schematic showing redox regulation of mKATP. 
Nitroxyl (HNO), RSNO, and LA- NO2 activate the channel, possibly via thiols on the channel 
itself or on complex II of the respiratory chain. The ability of low molecular weight thiols (RSH) 
to inhibit the channel may also be mediated via thiols on the channel or on complex II. In 
contrast, the effects of NADPH are likely no mediated via thiols. The ability of NO• to activate 
the channel may be mediated via the generation of secondary RNS (e.g. RSNO, LA-NO2, 
HNO), which can activate the channel via PKG-independent mechanisms, or via classical 
NO• protein kinase signaling. ROS (in particular H2O2) can also activate the channel, via 
mechanisms that may include thiol modification or protein kinase signaling. The nature of the 
interaction between complex II and the subunits of the mKATP channel itself remains to be 
elucidated. 
 
Mitochondria have been proposed as one of the main oxygen sensing organelles 
within the systemic and pulmonary vasculature (Firth et al. 2008) and one of the 
main factors affecting NO’s vasodilator action is mitochondrial activity. Recent 
research has shown the importance of mitochondrial ATP-sensitive potassium 
channels in the protective mechanism of ischemic preconditioning (Queliconi et al. 
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2010). These channels have been described as sensitive to reactive oxygen species 
(Figure 1). This means that the channels are regulated by the redox state of the 
localised mitochondria, determined (partially) by the presence of reactive oxygen 
species such as NO. As mitochondria regulate potassium channels in smooth 
muscle cells they have the potential to alter the effects on NO on vascular tension. It 
has also been noted that NO also has an independent affect upon the mitochondrial 
electron transport chain. It has been shown that NO displays an inhibitory effect on 
the electron transport chain at several complexes, including complex 1 and 3 (Brown 
2007). One result of NO’s inhibition on the transport chain is the production of 
superoxide, which has a very high affinity for NO and binds rapidly, forming ONOO-. 
This then causes an accumulative effect on NO’s inhibitory action (as ONOO- also 
causes inhibition). 
Methods 
Chemicals 
Phenylephrine was purchased from Sigma Chemical Company. This was prepared 
into 10µM, 100µM, 1mM and 10mM stock solutions through dilation with Tyrode’s 
buffer solution. Sodium nitroprusside was purchased from Sigma Chemical 
Company and was prepared into 10µM, 100µM and 1mM stock solutions with 
Tyrode’s buffer solution. Rotenone and antimysin-A were also purchased from 
Sigma Chemical Company and were prepared as 5µM stock solutions with Tyrode’s 
buffer solution. 
Solutions 
Tyrodes buffer solution was prepared freshly before carrying out experiments. The 
solution consisted of: sodium chloride at 140mM, glucose at 5.55mM, sodium 
bicarbonate at11.9 mM, potassium chloride at 2.68 mM, sodium dihydrogen 
orthophosphate 0.4 mM, calcium chloride at 1.84mM and magnesium chloride at 
1.4mM. All of these components were provided by the University of Plymouth. 
Preparation of tissue 
Male Wister rats (250-450g) were killed by cervical dislocation and decapitation in 
accordance with Schedule 1 (Appropriate methods of humane killing) to the Animals 
(Scientific Procedures) Act 1986. An incision was then made into the peritoneum and 
then up through the centre of the rib cage to the neck in order to access the heart. 
Connective tissue was cut away with precision scissors whilst using forceps to gently 
pull away the heart by holding the lungs away from the body. The descending aorta 
was then cut away from the spine (through connective tissue) and cut off as far down 
as possible. Any tissue not immediately in use was kept in Tyrode’s buffer solution 
and on ice to keep the tissue from dying. As much descending aorta as possible was 
removed from the heart and cleaned in a petri dish with fresh buffer solution. This 
involved cutting away all remaining connective tissue and fat with small scissors 
whilst using fine forceps to hold the vessel at the edges, gently so as not to damage 
the endothelial lining or affect vasodilatory action. The rest of the heart and lungs 
were then taken from the ice and placed into a petri dish lined with a base of wax 
and filled with buffer solution. Both of the lungs and the heart were held apart in the 
wax with pins. All remaining connective tissue, fat and unwanted vessels were 
carefully removed, leaving the heart and two lungs attached by the pulmonary artery. 
Each end of the vessel was clamped with forceps and then cut, as close to the 
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lungs/heart as possible to provide the most artery for experimentation. Both the aorta 
and pulmonary artery were then cut into appropriately sized sections: 5mm for aorta 
and 2mm for pulmonary artery. These segments of blood vessel were then kept in 
buffer, on ice until needed. 
Organ bath setup 
The volume of both organ baths 1 and 2 was measured at: 74ml for organ bath 1, 
and 68ml for organ bath 2. These were filled to their levels with buffer solution and 
kept at 37.5ºC in a water bath at all times. Hooks were prepared from stainless steel 
wire at a length of 7mm each. Two hooks were carefully slid through the lumen of the 
blood vessel, with one fixed to the base of the organ bath and the other attached to 
an isometric force transducer above (AD Instruments Isometric Force Transducer) as 
described previously (Kato et al. 1990), in order to suspend the vessel segments (As 
shown in Figure 1). The isometric force transducer was then calibrated to display 
force in grams with the LabChart software. This involved recording the addition of a 
1g weight to the transducer and setting this change in weight as 0g-1g on the 
software. Blood vessel segments were suspended in the organ bath, in buffer, at 2g 
tension. Each vessel was allowed 30 minutes to equilibrate. Carbogen, a mix of 95% 
oxygen and 5% carbon dioxide, was bubbled through the organ bath to provide 
oxygen for the tissue to survive. Forces were achieved through inducing constriction 
and dilation of the blood vessels through the use of phenylephrine and sodium 
nitroprusside respectively. Isometric tension forces were recorded using a force 
transducer coupled to an amplifier. These signals were converted to digital signalling 
through LabChart software. The information was constantly recorded by the 
LabChart software in a visual (graph) format.  
 
Figure 2: Organ bath setup. Shows mounting of vessel strip attached to isometric force 
Transducer, which is linked to the computer and LabChart software.
 
Confirmation of tissue integrity 
Before carrying out an experimental procedure on any piece of tissue it was first 
established whether the vessel was undamaged (within reason) through the 
dissection and mounting process. This involved adding phenylephrine at 1µM and 
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3µM concentrations and observing the level of contraction induced. With any 
significant contraction induced it was considered that the tissue was undamaged in 
terms of vasodilatory properties as it was still functioning perfectly with respect to the 
experiment. 
Data analysis and stats 
The data was analysed with the LabChart software by extrapolating the data into an 
excel spread-sheet. Average points of tension were taken at the equilibrated resting 
point and after the addition of any drugs to produce a table displaying the changes in 
tension at any point through each experiment. These figures were then converted 
into values to display the actual change in tension by taking their values from the 
maximal contraction. These new figures were then converted again to give 
percentages of contraction which were plotted against drug concentrations. 
Results 
Contraction of vessels with phenylephrine 
 Addition of phenylephrine achieved 100% contraction at a concentration of 100µM in 
strips of rat aorta, suspended in Tyrode’s buffer solution. At a concentration of 1µM 
however, the average contraction was over 50% (Fig.3) and upon administration of 
phenylephrine at 3µM contractions of 60%+ were consistently achieved. To avoid 
disruption of the mechanisms under investigation, a concentration of 3µM 
phenylephrine was chosen to induce contraction of aortic strips in each experimental 
procedure.  
 
 
Figure 3: Contraction of pulmonary artery with phenylephrine (Screen shot from LabChart 
Shows contraction of pulmonary artery with addition of 300nM, 1µM and 3µM phenylephrine; 
indicated by the first second and third dotted lines respectively). 
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Relaxing of vessels with sodium nitroprusside  
 
A
B 
Figure 4: A: Dose response of aorta to SNP. Points on graph indicate the percentage of 
maximal relaxation of the aorta at a certain concentration of SNP, ranging from 10nM to 
30µM SNP. B: Screen shot from LabChart. Shows relaxation of aorta with the addition of  
1µM SNP. 
 
Sodium nitroprusside (SNP) was used as the NO donor used to create a model of 
endothelial and pharmacological functioning in both pulmonary artery and aortic 
vessels. In sections of pulmonary artery the maximum relaxation was induced at a 
concentration of 300µM SNP, but high levels of relaxation were also achieved at 
much lower concentrations (Fig.5). On average, 3µM SNP resulted in a relaxation in 
excess of 80% (Fig.5) and a concentration of 300nM SNP caused an average 
relaxation of 69.36%. This shows the rapid activity of SNP at relatively low 
concentrations, with regards to vessel dilation. The findings show that the pulmonary 
vascular tissue has a high sensitivity to SNP at low concentrations as an average of 
40% of maximal relaxation was achieved with just 30nM SNP. The effect of SNP on 
the dilation of aortic tissue yielded less drastic effects, with a concentration of 300nM 
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causing only 32% of maximal relaxation (Fig.4 A), however maximal relaxation was 
reached at a lower final concentration of 30µM SNP. It is interesting to note that, at a 
concentration of 1µM SNP, both the pulmonary artery and aortic tissue average 
percentages of relaxation were almost identical; 76.5% with pulmonary and 76.3% 
with aorta. This concentration appears to be the point at which aortic tissue becomes 
sensitive to SNP as the difference in average relaxation rises by 44% with the 
increase from 300nM to 1µM SNP.  
 
 
Figure 5: Dose response of pulmonary to SNP. Points on the graph show the percentage of 
maximal relaxation  of the pulmonary artery at certain concentrations of SNP, ranging from 
10nM to 300µM SNP. 
 
Relaxation of pulmonary artery in the presence of rotenone  
 
 
Figure 6: Effects of rotenone on pulmonary dilation with SNP. Blue bars show the 
percentage of maximal relaxation of pulmonary artery at 1µM and 3µM SNP, in the presence 
of rotenone. Blue bars show percentage of maximal relaxation of pulmonary artery at 1µM 
and 3µM SNP, with no rotenone present (control group). 
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In the presence of rotenone (a mitochondrial electron transfer chain inhibitor at 
complex-1) the effects of SNP on the dilation of pulmonary artery sections were 
significantly increased in comparison to the control experiments (Fig.6). In the control 
studies a concentration of 1µM SNP resulted in 76.5% of maximal relaxation, but in 
the presence of rotenone this value was increased to 94%. Furthermore at 3µM SNP, 
whilst rotenone was present, maximal relaxation was induced, whilst the control 
model had only reached 83% at this concentration. Any concentration of SNP above 
3µM, in the presence of rotenone, always induced 100% of maximal relaxation in 
pulmonary artery strips. This shows the effect of rotenone on the sensitivity of 
pulmonary artery tissue to SNP, which is already highly sensitive to the drug. 
Relaxation of aorta in the presence of rotenone  
 
 
Figure 7: Example of dose response of aorta to SNP, in the presence of rotenone. Graph 
shows percentage of maximal relaxation of aorta at certain concentrations of SNP whilst 
rotenone was present. Graph shows 100% relaxation at low concentration of 300nM SNP. 
 
The addition of rotenone to strips of aorta resulted in drastic effects on the 
vasodilatory action of SNP, with a variety of different results extracted from various 
experiments. The most prominent contrast to control experiments was the dramatic 
reduction in the concentration of SNP needed to achieve maximal relaxation of the 
tissue. Due to the large variation in the figures obtained from each experiment, it was 
not possible to conclude any specific concentration at which maximal relaxation was 
achieved however in some cases this was as low as 30nM SNP. It should be noted 
that in one particular experiment (Fig.7) this concentration (30nM SNP) only caused 
39% of maximal relaxation, with 100% relaxation being reached at a concentration of 
300nM SNP. Any values for relaxation above 300nM SNP were considered arbitrary 
as, by this point, maximal relaxation had already been achieved and values tended 
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to fall lower than 100%. This is assumedly due to other factors, such as disturbance 
from gas bubbles or natural constriction, as opposed to the effects of the rotenone 
and SNP. In nearly every experiment of aortic dilation in the presence of rotenone it 
was only the first or second addition of SNP which resulted in relaxation. Any 
concentrations of SNP over 100nM which were added had no vasorelaxant action on 
aortic strips at all. Another interesting result from the addition of rotenone was not in 
the effect it had upon the vasorelaxant effects of SNP but rather a direct action on 
the aortic tissue itself. In one experiment the addition of rotenone alone was enough 
to induce vasodilation. This caused difficulty in acquisition of a dose response to 
SNP, as the tissue was already relaxing significantly. This result led the decision to 
change the protocol by adding the rotenone before contraction of the tissue, with 
phenylephrine, in further experiments. 
Relaxation of aorta in the presence of antimysin-A  
 
 
Figure 8: Effect of Antimysin-A on SNP induced dilation. Graph shows percentage of 
relaxation of aorta at different concentrations of SNP, in the presence of antimysin-A. 
Markedly low levels of relaxation at high concentrations of SNP (with comparison to controls). 
 
In none of the experiments with the inclusion of the mitochondrial electron transport 
chain inhibitor (at complex-3) antimysin-A was maximal relaxation from SNP 
achieved. In one of these experiments a value of 65% of maximal relaxation was 
reached with 3µM SNP; however the average value at this concentration was 46%. 
Though 65% relaxation was achieved at this concentration, values from lower 
concentrations of the same experiment showed no trend whatsoever. When the 
concentration of SNP was raised from 30nM to 100nM the level of relaxation actually 
dropped by 5%. On the whole values retrieved from the lower concentrations of SNP 
did not differ greatly from those of the control groups (Fig.8), but the aortic tissue 
samples were not very sensitive to SNP at low concentrations (with comparison to 
0
10
20
30
40
50
60
70
80
90
100
1 10 100 1000 10000
Relaxation of aorta with SNP in the presence of Anti-A 
10-8 10-7 1 -6 10-5 
Concentration of SNP in M 
P
e
rc
e
n
ta
g
e
 o
f 
m
a
x
im
a
l 
re
la
x
a
ti
o
n
 
The Plymouth Student Scientist, 2013, 6, (1), 16-31 
 
 
 
[26] 
 
the pulmonary tissue). It was at concentrations of 300nM and above that the effects 
of the antimysin-A were most notable in aortic tissue, with the average relaxation at 
this concentration being only 22% compared with 32% relaxation in control groups. 
As the concentration increases the effects of antimysin-A become more prominent, 
with the tissue failing to relax in response to the SNP. The direct inhibitory effects of 
antimysin-A on SNP’s action is highlighted by the consistency of the concentration at 
which SNP makes a significant change to vessel relaxation. In both control and 
antimysin-A treated experiments it was at 1µM SNP that the percentage of relaxation 
was significantly increased. It was halved however in the antimysin-A group, with the 
average increase in relaxation dropping from 44% to 22%. 
Discussion 
Vasodilation through NO 
This study highlights the importance of mitochondrial activity in the mediation of NO 
induced vasodilation in both aortic and pulmonary artery tissue. It has also shown 
the variation present between these two tissues with respect to their sensitivity to NO. 
Typically, NO is released by the endothelium in response to increased intracellular 
calcium concentration, in the endothelium. SNP was used as an NO donor drug to 
create a model of endogenous NO within vascular smooth muscle and endothelium. 
The study’s results showed the marked variation in NO sensitivity between the 
pulmonary artery and aorta, with concentrations of 300nM inducing over double the 
level of relaxation in pulmonary artery tissue than in the aortic samples. This 
supports previous findings that pulmonary vascular regulation is strongly influenced 
by NO (Merkus et al. 2004).  
Mediation of vasodilation by mitochondria 
Mitochondria play a crucial role in the regulation of vascular tone in both pulmonary 
and systemic vascular tissue. Specifically within the pulmonary vasculature, 
mitochondria have been proposed as the main organelle responsible for detection of 
oxygen concentration (Firth et al. 2008). Mitochondria have been shown to produce 
oxygen radicals in proportion to oxygen tension and play a role in the regulation of 
second messenger metabolism (Poburko et al. 2004). This study aimed to 
investigate the effects of inhibition of the mitochondrial electron transport chain at 
different complexes to help elucidate the mechanisms through which the 
mitochondria mediate vasorelaxation. It has been shown previously that, specifically 
within the pulmonary vasculature, mitochondria are co-localised to voltage gated 
potassium channels, responsible for the control of vascular tone (Bonnet and Archer 
2007). Mitochondria have been shown to mediate voltage gated potassium channels 
through magnesium ion and ATP-dependent mechanisms within pulmonary artery 
smooth muscle cells (Firth et al. 2008). It is known that in times of hypoxia the 
decreased oxygen concentration is detected by mitochondria which then inhibit 
potassium channels within the pulmonary artery; resulting in cell depolarisation and 
calcium influx. The pulmonary vasculature is unique in response to low levels of 
oxygen in that the blood vessel will contract, as opposed to relaxation induced within 
the systemic vasculature. By inhibiting the mitochondrial electron transport chain at 
complex 1 it was hypothesised to disrupt mitochondrial regulation of potassium 
channels, imitating conditions of hypoxia. The results obtained however gave 
opposing data, as rotenone would assumedly cause a reduction in SNP’s ability to 
induce vasodilation. It was instead found that the addition of rotenone increased the 
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vasodilation induced by SNP. As rotenone disrupts the mitochondrial electron 
transport chain it causes a change in the redox state surrounding the mitochondria. 
By adding rotenone at the beginning of the experiment the redox state of the 
mitochondria was altered before any addition of phenylephrine of SNP, which could 
cause changes in protein modification. This could be a potential cause of the 
unexpected results obtained. It is also possible that too high a concentration of 
rotenone was used leading to unwanted effects, as previous research shows use of 
lower concentrations (Navarro et al. 2010). Previous experiments into the effect of 
mitochondrial inhibition on pulmonary vasodilation were focused on the smooth 
muscle cells. As the endothelium was most likely still intact in this experiment, and 
NO has been shown to have opposing effects in endothelium and smooth muscle 
cells, this is a possible reason for the unexpected values recorded. Though 
mitochondria have been linked with potassium channel regulation in pulmonary 
smooth muscle, this relation has not been observed in aortic tissue. For this reason 
the same effects of inhibition of the mitochondrial transport chain were not expected 
in aortic strips. The results however again showed an increase in vasodilation from 
SNP with the presence of rotenone. It is possible that the addition of rotenone alone 
caused a change in redox state of the mitochondria present and resulted in changes 
in potassium channel activity. This idea is supported by the fact that in some cases 
the addition of rotenone alone actually resulted in vasodilation within the aorta. This 
suggests some possible unexplored linkage between mitochondria and potassium 
channels outside the pulmonary vasculature.  
Unlike the results obtained from experiments with rotenone, the use of antimysin-A 
to inhibit the mitochondrial electron transport chain at complex 1 caused an inhibition 
of vasodilator functioning of NO. Whilst the general trend of dilation was similar to 
that of the controls, with the same sensitivity to concentration, the effects of SNP 
were stunted, with much lower average values obtained at each concentration. The 
stark contrast between results from experiments with rotenone and antimysin-A 
highlight the specificity of certain complexes within the mitochondria and shows the 
importance of mitochondrial function in the regulation of vascular tension within the 
systemic vasculature. 
Limitations of experiment 
Many issues occurred during the conduct of these experiments which would call for 
changes if they were to be repeated. The first problems to identify themselves were 
with the dissection of the rats. Whilst the entire aorta is a fairly large and identifiable 
structure, with easy dissection, the pulmonary artery of a rat is a very small vessel. 
On top of this, it is partly concealed by the trunk of the aorta, connective tissue and 
surrounding fat. Removal of surrounding fat and connective tissue warrants extreme 
care and precision, and even when taking care it is very easy to accidentally cut into 
the pulmonary artery and cause problematic damage to the tissue. Another problem 
is with the removal of surrounding vessels; even when the pulmonary artery is left 
undamaged, the removal of other vessels (in order to open access to the pulmonary) 
results in the outlet of a large level of blood and clots, which mask the pulmonary 
artery even further. If this experiment were to be repeated there should be the 
proposal of an alternative dissection setup. Firstly, a slightly angled setup, with a 
slow and steady flow of buffer over the tissue would allow consistent washing of the 
heart and lungs whilst dissecting. This would prevent the build up of blood and clots, 
which hinder vision of the tissue. It would also be appropriate to include a dissection 
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microscope for the pulmonary dissection, as this involves a high level of precision 
and deals with a very small vessel. 
Time was another factor with serious implications on the control and 
reliability/reproducibility of the experiments. As time was limited to around 2 months, 
along with laboratory availability, the number of experiments which could be carried 
out was limited. Ideally there would have been further repeats of the effects of 
rotenone on pulmonary dilation to acquire realistic average values at each 
concentration. This means that if the experiments were repeated then they may 
produce significantly different results. There was also no time available to investigate 
the effects of antimysin-A on the dilation of the pulmonary artery, which would have 
provided further information to elucidate the difference in mechanisms of 
vasorelaxation between the two tissue types. Further more, repeats of the 
experiments using Angeli’s salts, in replacement of SNP, would have provided 
interesting information on the use of the novel nitroxyl (NHO) ion, as opposed to 
endogenous NO for pharmaceutical use in vascular disorder therapy. As the 
experiments were carried out over a 2 month period, the size of the rats involved 
varied greatly due to growth. Ideally the weight of the rats used would not vary more 
than 100g, but by the end of the experimentation period certain rats had grown much 
larger than anticipated, increasing the range in weights to 200g. As the control 
experiments were generally carried out earlier on in the 2 month period the average 
weight was most likely much lower for the control rats. This could cause unwanted 
variation and lower the reliability of the results obtained. There is also the time 
between death of the rats and removal of the desired tissues. As all rats for use in a 
single day’s experimentation were killed at the start of the day, there were issues 
concerning the quality of the tissue and actual removal of the tissue with later 
experiments. The longer time between death and dissection means an increase in 
the level of clotting of the blood, adding difficulty to the dissection. It also means that 
the tissue is much more likely to have died, and results from older tissue samples 
may have produced lower values, skewing the averages used in the results. 
Finally the apparatus used were not all ideal for the acquisition of perfect data. One 
issue was the setup of the gas bubbles through the organ bath. The tube for gas 
delivery was only able to pump gas fairly close to the suspended tissue. This often 
caused a great deal of disturbance and ‘noise’ on the LabChart software. The control 
of the gas outlet was also fairly unresponsive, resulting in many cases of overly 
vigorous oxygen bubbling. This could disturb the tissue and affect results. There was 
also a common occurrence of large gas bubbles becoming trapped within the fluid 
outlet pipe. These could be difficult to remove and would have altered the total 
volume of the organ bath, affecting the precision of the concentrations of drugs 
added to the experiment. At one point during experimentation the carbogen gas tank 
ran out and supplies were depleted for some time after this. This put a hold on any 
further experimentation and added a significant burden on the time restrictions 
already in place. The clamps that held the base of the organ bath in place were also 
inadequate. On many occasions, once equilibrating, the organ bath would slip within 
the clamp and caused the need to reset the equipment. This wasted time but also 
raises the possibility that slightly less drastic slips (during experiments) may have 
been missed, or interpreted as data relating to vasorelaxation. Were this study to be 
repeated, a much more reliable clamp setup would be needed to ensure consistency 
of results. The last consideration of lab apparatus hindrances is in the actual 
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laboratory itself. As this was often in use by others, space was limited, meaning that 
certain aspects (such as dissection) had to be carried out in slightly inappropriate 
areas, such as spaces with low levels of lighting. When carrying out a difficult 
dissection a well-lit workplace is essential and this was often not available. 
Conclusions and considerations for further research 
In conclusion the relationship between mitochondria and NO induced vasodilation is 
still yet to be fully understood. The importance of voltage gated potassium channels 
has become clear and the regulation of these channels through mitochondrial activity 
shows great importance in both the pulmonary and systemic vasculature. Future 
research should aim to investigate the effects of inhibition at different mitochondrial 
complexes whilst under conditions of low oxygen concentration within the pulmonary 
artery. It should also be recognised that reactive oxygen species produced by 
mitochondria themselves also contribute to vascular tone regulation and therefore 
careful examination of the relationship between mitochondrial and endothelial 
reactive oxygen species may provide vital information on how this system is 
regulated. Furthermore, a better understanding of how mitochondria regulate 
vasodilation could provide useful insight into the morphological changes in 
mitochondria, presumed to be an underlying cause of many cardiovascular diseases, 
including diabetes mellitus.  
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